SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Y2k_fan who wrote (336)5/21/1998 12:07:00 AM
From: Jeffrey L. Henken  Read Replies (2) of 2887
 
Over at Yahoo another buy out rumor of American BioMed appeared again today. This was my answer:

JNJ + ABMI???

Yes we have all heard this rumor.

Yes it is a possibility but I believe that these things are like birthday wishes...

If you tell everyone then it won't come true!

But just for the sake of argument why might it happen? ABMI's 27 patents, an outstanding 100% silicone catheter line, the OmniCath which should resume phase II testing soon, the Guidewire MicroFilter and other technologies that JNJ and no one else but the American BioMed division would then possess.

Is this an actual possibility in reality?

Lets look at some statements from JNJ and I'll ask you to draw your own conclusions:

"Johnson & Johnson Outlines 'Platforms for Growth' Increases Dividend for 36th Consecutive Year

biz.yahoo.com

R&D Spending to Exceed $2.3 Billion in 1998

Larsen cited the importance of continuing to invest heavily in research and development, estimated an R&D expenditure of between $2.3 and $2.4 billion in 1998 (a record for Johnson & Johnson) and emphasized that R&D investment across the corporation is one of several fundamental strategies in the pursuit of growth.

The others, he noted, are to continue to aggressively pursue licensing, outside investment and acquisition opportunities; as well as maintaining a commitment to productivity and cost efficiency."


It could happen.

It might happen.

Just close your eyes and make a wish but for God sakes lets stop talking about it!


In all seriousness American BioMed does possess some truly outstanding technology. Why they have not already been acquired is beyond me. Just because something has not yet occurred simply does not mean it will never happen.

These kinds of things always seem to happen when you least expect it

At the very least I expect to see this company form a strategic partnership or two before the year is out which will facilitate bringing products in R&D to market.

Does this have to happen for American BioMed to succeed?

Certainly not, especially with the $5 million equity line of credit but it sure will(I hope, I hope, I hope) Help!

GO ABMI!

Regards, Jeff

GO ABMI!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext